Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$16.95 - $27.04 $8.99 Million - $14.3 Million
530,091 Added 133.78%
926,327 $25 Million
Q1 2024

May 13, 2024

BUY
$11.38 - $19.03 $3.18 Million - $5.32 Million
279,360 Added 239.02%
396,236 $7.26 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $10,856 - $27,132
1,726 Added 1.5%
116,876 $1.43 Million
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $1.49 Million - $3.25 Million
-99,601 Reduced 46.38%
115,150 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $115,379 - $178,884
-3,877 Reduced 1.77%
214,751 $6.98 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $1.67 Million - $2.53 Million
43,825 Added 25.07%
218,628 $8.55 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $3.08 Million - $4.27 Million
75,911 Added 76.76%
174,803 $9.24 Million
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $88,197 - $117,342
-2,385 Reduced 2.35%
98,892 $4.45 Million
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $44,819 - $73,234
-1,599 Reduced 1.55%
101,277 $3.69 Million
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $36,783 - $55,427
1,258 Added 1.24%
102,876 $3.95 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $1.25 Million - $1.95 Million
-31,670 Reduced 23.76%
101,618 $3.95 Million
Q3 2021

Nov 12, 2021

SELL
$44.0 - $65.8 $939,576 - $1.41 Million
-21,354 Reduced 13.81%
133,288 $7.76 Million
Q2 2021

Aug 16, 2021

BUY
$44.66 - $63.06 $766,320 - $1.08 Million
17,159 Added 12.48%
154,642 $7.4 Million
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $102,159 - $138,316
-2,206 Reduced 1.58%
137,483 $6.96 Million
Q4 2020

Feb 16, 2021

SELL
$55.51 - $69.94 $2.04 Million - $2.57 Million
-36,761 Reduced 20.83%
139,689 $8.8 Million
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $1.44 Million - $2.37 Million
-34,081 Reduced 16.19%
176,450 $11.9 Million
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $482,180 - $757,486
17,502 Added 9.07%
210,531 $8.82 Million
Q1 2020

May 14, 2020

SELL
$23.16 - $47.8 $663,140 - $1.37 Million
-28,633 Reduced 12.92%
193,029 $6.08 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $3.13 Million - $4.52 Million
111,906 Added 101.96%
221,662 $8.95 Million
Q3 2019

Nov 14, 2019

SELL
$31.65 - $46.94 $219,018 - $324,824
-6,920 Reduced 5.93%
109,756 $3.57 Million
Q2 2019

Aug 15, 2019

BUY
$32.5 - $49.12 $3.79 Million - $5.73 Million
116,676 New
116,676 $5.65 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.